The federal fraud case against the top executives of the failed biotech company Theranos posed an interesting tale of two different trials. 'The Dropout' host RebeccaJarvis breaks it down:
The company claimed it could run any blood test using only a few drops of blood via its so-called proprietary technology. However, according to prosecutors, their product, a machine called "Edison," could never run more than a dozen blood tests at a time.
"[The abuse claims] did not come up at his trial, but for during [Holmes'] seven days of testimony, they were a big portion of what she talked about," Jarvis told "Start Here." "You can imagine where the jury may have found that presentation more sympathetic than Sunny Balwani who had experience," she said.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Sunny Balwani trial update: Former Theranos President found guilty on all counts in fraud caseA verdict has been reached in the trial of former Theranos President Sunny Balwani.
Read more »
Sunny Balwani trial update: Former Theranos President found guilty on all counts in fraud caseA verdict has been reached in the trial of former Theranos President Sunny Balwani.
Read more »
Sunny Balwani trial update: Former Theranos president found guilty on all counts in fraud caseA verdict has been reached in the trial of former Theranos President Sunny Balwani.
Read more »
Former Theranos COO Sunny Balwani Found Guilty on 12 Counts in FraudElizabeth Holmes’ ex-boyfriend and Theranos’ former COO Sunny Balwani has been convicted of fraud.
Read more »
Theranos Ex-CEO Sunny Balwani Found Guilty in All 12 Fraud Charges 6 Months After Founder Holmes' ConvictionThe jury in former Theranos executive Ramesh “Sunny” Balwani reached a verdict on Thursday.
Read more »
Former Theranos executive Sunny Balwani convicted in criminal fraud caseBREAKING: Former Theranos president Ramesh “Sunny” Balwani found guilty of defrauding investors and patients in connection with his blood-testing startup.
Read more »